Salomon & Ludwin’s Insmed INSM Stock Holding History

Salomon & Ludwin’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-55	Closed	-$8.93K	–	2138
2026 Q1	$8.93K	Buy	55 +3	+6%	+$461	﹤0.01%	1564
2025 Q4	$9.11K	Hold	52	–	–	﹤0.01%	1498
2025 Q3	$8.17K	Buy	+52	New	+$6.37K	﹤0.01%	1462

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Salomon & Ludwin's INSM Position: Q2 2026 in Review

Salomon & Ludwin sold out of Insmed (INSM) in Q2 2026, closing a stake of 55 shares — an estimated $8.93K sold.

Salomon & Ludwin first reported a position in INSM in Q3 2025 and held it in 3 quarters. The position peaked at $9.11K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Salomon & Ludwin reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Salomon & Ludwin sold 55 Insmed shares in Q2 2026, an estimated $8.93K.
Salomon & Ludwin first reported a position in Insmed in Q3 2025 and held it in 3 quarters.
Salomon & Ludwin's Insmed position peaked at $9.11K in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.